A dementia vaccine — which is the brainchild of a South Australian academic — is on the cusp of starting human trials, with researchers hopeful it will be the "breakthrough of the next decade".
Key points:
- Professor Nikolai Petrovsky hopes human trials will start within the next two years
- The vaccine is designed to be both preventative and therapeutic
- Research is being led by the University of California and Institute for Molecular Medicine
Flinders University Professor Nikolai Petrovsky said the team of researchers had completed successful testing on mice, which had been "genetically programmed to get dementia and Alzheimer's disease".
"We were able to prevent the memory loss in the mice and obviously the next step is to take this into human clinical trials,"
https://tinyurl.com/udchhj2